These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 10685634)
1. Histopathologic analysis of chromosome aneuploidy in ductal carcinoma in situ. Visscher D; Jimenez RE; Grayson M; Mendelin J; Wallis T Hum Pathol; 2000 Feb; 31(2):201-7. PubMed ID: 10685634 [TBL] [Abstract][Full Text] [Related]
2. Analysis of chromosome aneuploidy in breast carcinoma progression by using fluorescence in situ hybridization. Mendelin J; Grayson M; Wallis T; Visscher DW Lab Invest; 1999 Apr; 79(4):387-93. PubMed ID: 10211991 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of chromosome aneuploidy in tissue sections of preinvasive breast carcinomas using interphase cytogenetics. Visscher DW; Wallis TL; Crissman JD Cancer; 1996 Jan; 77(2):315-20. PubMed ID: 8625240 [TBL] [Abstract][Full Text] [Related]
4. Abnormal chromosome 8 copy number in cytological smears from breast carcinomas detected by means of fluorescence in situ hybridization (FISH). Bofin AM; Ytterhus B; Fjøsne HE; Hagmar BM Cytopathology; 2003 Feb; 14(1):5-11. PubMed ID: 12588304 [TBL] [Abstract][Full Text] [Related]
5. Characterization of extensive genetic alterations in ductal carcinoma in situ by fluorescence in situ hybridization and molecular analysis. Murphy DS; Hoare SF; Going JJ; Mallon EE; George WD; Kaye SB; Brown R; Black DM; Keith WN J Natl Cancer Inst; 1995 Nov; 87(22):1694-704. PubMed ID: 7473818 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of numerical abnormalities of chromosomes 1 and 17 in proliferative epithelial breast lesions using fluorescence in situ hybridization. Marinho AF; Botelho M; Schmitt FC Pathol Res Pract; 2000; 196(4):227-33. PubMed ID: 10782466 [TBL] [Abstract][Full Text] [Related]
7. Diagnosis of ductal carcinoma in situ (DCIS) and intraductal papilloma using fluorescence in situ hybridization (FISH) analysis. Komoike Y; Motomura K; Inaji H; Koyama H Breast Cancer; 2000; 7(4):332-6. PubMed ID: 11114860 [TBL] [Abstract][Full Text] [Related]
8. Chromosome 1 aneusomy, identified by interphase cytogenetics, in mammographically detected ductal carcinoma in situ of the breast. Harrison M; Magee HM; O'Loughlin J; Gorey TF; Dervan PA J Pathol; 1995 Mar; 175(3):303-9. PubMed ID: 7745499 [TBL] [Abstract][Full Text] [Related]
9. Determination of Her-2/Neu status in breast carcinoma: comparative analysis of immunohistochemistry and fluorescent in situ hybridization. Jimenez RE; Wallis T; Tabasczka P; Visscher DW Mod Pathol; 2000 Jan; 13(1):37-45. PubMed ID: 10658908 [TBL] [Abstract][Full Text] [Related]
10. Alteration of numerical chromosomal aberrations during progression of colorectal tumors revealed by a combined fluorescence in situ hybridization and DNA ploidy analysis of intratumoral heterogeneity. Katsura K; Sugihara H; Nakai S; Fujita S Cancer Genet Cytogenet; 1996 Sep; 90(2):146-53. PubMed ID: 8830725 [TBL] [Abstract][Full Text] [Related]
11. Fluorescence in situ hybridization assessment of chromosome 8 copy number in stage I and stage II infiltrating ductal carcinoma of the breast. Afify A; Mark HF Cancer Genet Cytogenet; 1997 Sep; 97(2):101-5. PubMed ID: 9283590 [TBL] [Abstract][Full Text] [Related]
12. Karyotypic heterogeneity and its relation to labeling index in interphase breast tumor cells. Balazs M; Matsumura K; Moore D; Pinkel D; Gray JW; Waldman FM Cytometry; 1995 May; 20(1):62-73. PubMed ID: 7600900 [TBL] [Abstract][Full Text] [Related]
13. Stage I and stage II infiltrating ductal carcinoma of the breast analyzed for chromosome 8 copy number using fluorescent in situ hybridization. Mark HF; Taylor W; Afify A; Riera D; Rausch M; Huth A; Gray Y; Santoro K; Bland KI Pathobiology; 1997; 65(4):184-9. PubMed ID: 9396041 [TBL] [Abstract][Full Text] [Related]
14. Prognostic value of chromosome 1 and 8 copy number in invasive ductal breast carcinoma among Iranian women: an interphase FISH analysis. Behjati F; Atri M; Najmabadi H; Nouri K; Zamani M; Mehdipour P Pathol Oncol Res; 2005; 11(3):157-63. PubMed ID: 16195769 [TBL] [Abstract][Full Text] [Related]
15. Correlation of HER2 overexpression with gene amplification and its relation to chromosome 17 aneuploidy: a 5-year experience with invasive ductal and lobular carcinomas. Nassar A; Khoor A; Radhakrishnan R; Radhakrishnan A; Cohen C Int J Clin Exp Pathol; 2014; 7(9):6254-61. PubMed ID: 25337277 [TBL] [Abstract][Full Text] [Related]
16. Interphase cytogenetic analysis of erbB2 and topoII alpha co-amplification in invasive breast cancer and polysomy of chromosome 17 in ductal carcinoma in situ. Murphy DS; McHardy P; Coutts J; Mallon EA; George WD; Kaye SB; Brown R; Keith WN Int J Cancer; 1995 Feb; 64(1):18-26. PubMed ID: 7665243 [TBL] [Abstract][Full Text] [Related]
17. Genetic progression, histological grade, and allelic loss in ductal carcinoma in situ of the breast. Fujii H; Szumel R; Marsh C; Zhou W; Gabrielson E Cancer Res; 1996 Nov; 56(22):5260-5. PubMed ID: 8912866 [TBL] [Abstract][Full Text] [Related]
18. Chromosomal aneuploidy precedes morphological changes and supports multifocality in head and neck lesions. Ai H; Barrera JE; Meyers AD; Shroyer KR; Varella-Garcia M Laryngoscope; 2001 Oct; 111(10):1853-8. PubMed ID: 11801957 [TBL] [Abstract][Full Text] [Related]
19. Extensive ductal carcinoma In situ with small foci of invasive ductal carcinoma: evidence of genetic resemblance by CGH. Aubele M; Mattis A; Zitzelsberger H; Walch A; Kremer M; Welzl G; Höfler H; Werner M Int J Cancer; 2000 Jan; 85(1):82-6. PubMed ID: 10585588 [TBL] [Abstract][Full Text] [Related]
20. Aneuploidy of chromosome 8 as detected by interphase fluorescence in situ hybridization is a recurrent finding in primary and metastatic breast cancer. Roka S; Fiegl M; Zojer N; Filipits M; Schuster R; Steiner B; Jakesz R; Huber H; Drach J Breast Cancer Res Treat; 1998 Mar; 48(2):125-33. PubMed ID: 9596484 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]